Back to Search
Start Over
Donanemab-azbt (Kisunla).
- Source :
-
Internal Medicine Alert . 8/15/2024, Vol. 46 Issue 15, p1-8. 8p. - Publication Year :
- 2024
-
Abstract
- The article reports on the approval by the U.S. Food and Drug Administration on Donanemab, a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody, for the treatment of Alzheimer's disease, following aducanumab and lecanemab.
Details
- Language :
- English
- ISSN :
- 0195315X
- Volume :
- 46
- Issue :
- 15
- Database :
- Academic Search Index
- Journal :
- Internal Medicine Alert
- Publication Type :
- Periodical
- Accession number :
- 179361093